|
US4996335A
(en)
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
US4757128A
(en)
|
1986-08-01 |
1988-07-12 |
Massachusetts Institute Of Technology |
High molecular weight polyanhydride and preparation thereof
|
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
CH671402A5
(enExample)
|
1985-10-02 |
1989-08-31 |
Sandoz Ag |
|
|
GB8601100D0
(en)
|
1986-01-17 |
1986-02-19 |
Cosmas Damian Ltd |
Drug delivery system
|
|
US4789724A
(en)
|
1986-10-17 |
1988-12-06 |
Massachusetts Institute Of Technology |
Preparation of anhydride copolymers
|
|
US5718921A
(en)
|
1987-03-13 |
1998-02-17 |
Massachusetts Institute Of Technology |
Microspheres comprising polymer and drug dispersed there within
|
|
US4839343A
(en)
|
1987-03-13 |
1989-06-13 |
Debiopharm, S.A. |
Preparation containing hexatriacontapeptides and methods of use
|
|
CA1325382C
(en)
|
1988-01-27 |
1993-12-21 |
Takahiro Ogawa |
Locally administrable therapeutic composition for inflammatory disease
|
|
US4868274A
(en)
|
1988-05-23 |
1989-09-19 |
Hoechst Celanese Corp. |
Polyanhydride from carboxy aryloxy alkanoic acid
|
|
US4999417A
(en)
|
1989-03-30 |
1991-03-12 |
Nova Pharmaceutical Corporation |
Biodegradable polymer compositions
|
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5696298A
(en)
|
1991-03-19 |
1997-12-09 |
Cytrx Corporation |
Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
|
|
BR9306038A
(pt)
|
1992-02-28 |
1998-01-13 |
Univ Texas |
Hidrogéis biodegradáveis fotopolimerizáveis como materiais de contato de tecidos e condutores de liberação controlada
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
AU660852B2
(en)
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5429824A
(en)
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
|
US5364884A
(en)
|
1993-01-21 |
1994-11-15 |
Baylor College Of Medicine |
Arginine compounds as ocular hypotensive agents
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5534259A
(en)
|
1993-07-08 |
1996-07-09 |
Liposome Technology, Inc. |
Polymer compound and coated particle composition
|
|
WO1995003356A1
(en)
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5540930A
(en)
|
1993-10-25 |
1996-07-30 |
Pharmos Corporation |
Suspension of loteprednol etabonate for ear, eye, or nose treatment
|
|
CA2180424C
(en)
|
1994-02-14 |
1999-05-04 |
Pankaj Modi |
Drugs, vaccines and hormones in polylactide coated microspheres
|
|
GB9406094D0
(en)
|
1994-03-28 |
1994-05-18 |
Univ Nottingham And University |
Polymer microspheres and a method of production thereof
|
|
US5718388A
(en)
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
US5628981A
(en)
|
1994-12-30 |
1997-05-13 |
Nano Systems L.L.C. |
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
|
|
US5665331A
(en)
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
|
DE19511322C2
(de)
|
1995-03-28 |
1999-09-02 |
Mann Gerhard Chem Pharm Fab |
Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
|
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
WO1997020578A1
(en)
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
|
DE19614823A1
(de)
|
1996-04-15 |
1997-10-16 |
Mann Gerhard Chem Pharm Fab |
Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US6517860B1
(en)
|
1996-12-31 |
2003-02-11 |
Quadrant Holdings Cambridge, Ltd. |
Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
|
|
US6106819A
(en)
|
1996-12-31 |
2000-08-22 |
Sucher; David F. |
Methods of treating headache and functional extraocular and intraocular myotendinitis
|
|
CA2277801C
(en)
|
1997-01-16 |
2002-10-15 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5800807A
(en)
|
1997-01-29 |
1998-09-01 |
Bausch & Lomb Incorporated |
Ophthalmic compositions including glycerin and propylene glycol
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5869130A
(en)
|
1997-06-12 |
1999-02-09 |
Mac Dermid, Incorporated |
Process for improving the adhesion of polymeric materials to metal surfaces
|
|
GB9713980D0
(en)
|
1997-07-03 |
1997-09-10 |
Danbiosyst Uk |
New conjugates
|
|
US6165509A
(en)
|
1998-09-01 |
2000-12-26 |
University Of Washington |
Pegylated drug complexed with bioadhesive polymer suitable for drug delivery and methods relating thereto
|
|
US6372246B1
(en)
|
1998-12-16 |
2002-04-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals
|
|
WO2000040203A2
(en)
|
1999-01-08 |
2000-07-13 |
Emisphere Technologies, Inc. |
Polymeric delivery agents and delivery agent compounds
|
|
DE60013773T2
(de)
|
1999-02-03 |
2005-11-10 |
Biosante Pharmaceuticals, Inc. |
Methoden zur Herstellung von therapeutischen Kalziumphosphat Partikeln
|
|
US20020068090A1
(en)
|
1999-02-03 |
2002-06-06 |
Bell Steve J. D. |
Calcium phosphate particles as mucosal adjuvants
|
|
US20040258763A1
(en)
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
|
DE60020382T2
(de)
|
1999-09-21 |
2006-01-26 |
Skyepharma Canada Inc., Verdun |
Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
|
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
PE20020146A1
(es)
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
AU2000202A
(en)
|
2000-10-31 |
2002-05-15 |
Pr Pharmaceuticals Inc |
Methods and compositions for enhanced delivery of bioactive molecules
|
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
|
US6703039B2
(en)
|
2000-12-06 |
2004-03-09 |
Bausch & Lomb Incorporated |
Reversible gelling system for ocular drug delivery
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
GB2370839A
(en)
|
2001-01-06 |
2002-07-10 |
Benedikt Timmerman |
Immunogenic complex useful for disease control
|
|
EP1406593B1
(en)
|
2001-06-22 |
2010-08-25 |
Johns Hopkins University School of Medicine |
Biodegradable polymer compositions, compositions and uses related thereto
|
|
GB0122318D0
(en)
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
US20050191359A1
(en)
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
|
US20090215735A1
(en)
|
2002-02-25 |
2009-08-27 |
Alcon, Inc. |
Topical solution formulations containing a corticosteroid and a cyclodextrin
|
|
AU2006220411B2
(en)
|
2002-03-20 |
2008-06-26 |
Alkermes, Inc. |
Inhalable Sustained Therapeutic Formulations
|
|
WO2003103632A1
(en)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
|
UA82323C2
(uk)
|
2002-08-09 |
2008-04-10 |
Меда Фарма Гмбх & Ко. Кг |
Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
|
|
CA2500218A1
(en)
|
2002-09-26 |
2004-04-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug absorptivity improving agent
|
|
DE10248619A1
(de)
|
2002-10-18 |
2004-04-29 |
Bayer Ag |
Verfahren zur Herstellung pulverförmiger Wirkstoff-Formulierungen mit kompressiblen Fluiden
|
|
CA2510199A1
(en)
|
2002-12-17 |
2004-07-08 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
|
|
KR101045504B1
(ko)
|
2002-12-30 |
2011-06-30 |
넥타르 테라퓨틱스 |
약물 전달 부형제로서의 멀티-아암 폴리펩티드-폴리(에틸렌글리콜) 블록 공중합체
|
|
US7060299B2
(en)
|
2002-12-31 |
2006-06-13 |
Battelle Memorial Institute |
Biodegradable microparticles that stabilize and control the release of proteins
|
|
US20040208833A1
(en)
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
US20050266090A1
(en)
|
2003-04-29 |
2005-12-01 |
Ales Prokop |
Nanoparticular targeting and therapy
|
|
US20050058603A1
(en)
|
2003-05-02 |
2005-03-17 |
Case Western Reserve University |
Drug delivery system based on polymer nanoshells
|
|
CA2523035C
(en)
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
US20050065901A1
(en)
|
2003-07-09 |
2005-03-24 |
Board Of Regents, The University Of Texas System |
Methods and systems for simultaneous multiple frequency voltage generation
|
|
US20050009910A1
(en)
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
WO2005014524A2
(en)
|
2003-08-07 |
2005-02-17 |
Wisconsin Alumni Research Foundation |
Amino thiol compounds and compositions for use in conjunction with cancer therapy
|
|
US20050065091A1
(en)
*
|
2003-09-18 |
2005-03-24 |
Gholam Peyman |
Stabilized ocular solutions
|
|
US20050095205A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Ramesh Krishnamoorthy |
Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
|
|
US20090148527A1
(en)
|
2007-12-07 |
2009-06-11 |
Robinson Michael R |
Intraocular formulation
|
|
US20080306039A1
(en)
*
|
2003-12-02 |
2008-12-11 |
Keiichi Matsuhisa |
Loteprednol Etabonate Aqueous Suspension
|
|
GB0328630D0
(en)
|
2003-12-10 |
2004-01-14 |
Medpharm Ltd |
Metered dose inhalation preparations
|
|
JP2007517016A
(ja)
|
2003-12-31 |
2007-06-28 |
ファイザー・プロダクツ・インク |
低溶解性薬剤及びポロキサマーの固体組成物
|
|
WO2005072710A2
(en)
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
US20090247604A1
(en)
|
2004-02-05 |
2009-10-01 |
Intradigm Corporation |
RNAi Therapeutics for Treatment of Eye Neovascularization Diseases
|
|
US20050182039A1
(en)
|
2004-02-13 |
2005-08-18 |
Bausch & Lomb Incorporated |
Use of Loteprednol etabonate for the treatment of dry eye
|
|
WO2005084710A2
(en)
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
|
JP2007530573A
(ja)
|
2004-03-25 |
2007-11-01 |
ボーシュ アンド ローム インコーポレイティド |
ドライアイの治療にロテプレドノールエタボネートを使用すること
|
|
US20060018949A1
(en)
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
|
MXPA06011871A
(es)
|
2004-04-15 |
2007-10-08 |
Chiasma Inc |
Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
WO2005107708A1
(en)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase inhibitors implants
|
|
EP1768692B8
(en)
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
CA2579957A1
(en)
|
2004-09-14 |
2006-03-23 |
Nanodel Technologies Gmbh |
Delivery vehicle containing nanoparticles
|
|
US7495052B2
(en)
|
2004-09-15 |
2009-02-24 |
Bausch & Lomb Incorporated |
Method for the production of polymerized nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
|
|
CA2580659C
(en)
|
2004-09-15 |
2013-02-26 |
Ivx Animal Health, Inc. |
Corticosteroid having low systemic absorption
|
|
CN101890167B
(zh)
|
2004-10-01 |
2017-03-01 |
拉姆斯科股份有限公司 |
可方便植入的缓释药物组合物
|
|
US20060083781A1
(en)
|
2004-10-14 |
2006-04-20 |
Shastri V P |
Functionalized solid lipid nanoparticles and methods of making and using same
|
|
US8758816B2
(en)
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
WO2006062875A1
(en)
|
2004-12-08 |
2006-06-15 |
Merck & Co., Inc. |
Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
|
|
EP1856179B1
(en)
|
2004-12-10 |
2013-05-15 |
Kala Pharmaceuticals, Inc. |
Functionalized poly (ether-anhydride) block copolymers
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
BRPI0608173A2
(pt)
|
2005-02-24 |
2010-11-09 |
Elan Pharma Int Ltd |
composição, uso da mesma, e, método de produzir uma composição de docetaxel nanoparticulada ou análogo do mesmo
|
|
US20080145432A1
(en)
|
2005-03-09 |
2008-06-19 |
Yoshinori Kakizawa |
Fine Particle and Pharmaceutical Preparation
|
|
DE102005011786A1
(de)
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
DK1885336T3
(da)
|
2005-05-10 |
2009-05-25 |
Alcon Inc |
Suspensionsformuleringer, der omfatter et aktivt princip, et overfladeaktivt poloxamer- eller meroxapolmiddel og en glycol, samt deres anvendelse til fremstilling af et medikament til behandling af öjenlidelser
|
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
|
US7893040B2
(en)
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
|
WO2007034479A2
(en)
|
2005-09-20 |
2007-03-29 |
Yissum Research Development Company |
Nanoparticles for targeted delivery of active agents
|
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
|
US20070093461A1
(en)
|
2005-10-26 |
2007-04-26 |
Bausch & Lomb Incorporated |
Effect of Loteprednol etabonate on vascular dysfunction
|
|
WO2007058935A2
(en)
|
2005-11-14 |
2007-05-24 |
Bausch & Lomb Incorporated |
Ophthalmic composition for dry eye therapy
|
|
CA2631757A1
(en)
|
2005-12-02 |
2007-06-07 |
Elan Pharma International Limited |
Novel mometasone compositions and methods of making and using the same
|
|
US20090155182A1
(en)
|
2005-12-09 |
2009-06-18 |
Invitrogen Corporation |
Optical in vivo imaging contrast agents and methods of use
|
|
KR20080089344A
(ko)
*
|
2005-12-14 |
2008-10-06 |
에프. 호프만-라 로슈 아게 |
Ｃ형 간염 바이러스(ｈｃｖ) 전구약물 제형
|
|
US7544371B2
(en)
|
2005-12-20 |
2009-06-09 |
Bausch + Lomb Incorporated |
Drug delivery systems
|
|
WO2007076358A1
(en)
|
2005-12-23 |
2007-07-05 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
US20070149480A1
(en)
|
2005-12-23 |
2007-06-28 |
Alcon, Inc. |
PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
WO2007084418A2
(en)
|
2006-01-13 |
2007-07-26 |
Surmodics, Inc. |
Microparticle containing matrices for drug delivery
|
|
US20070178051A1
(en)
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
US20070212420A1
(en)
|
2006-03-10 |
2007-09-13 |
Bausch & Lomb Incorporated |
Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
|
|
US20070218104A1
(en)
|
2006-03-15 |
2007-09-20 |
Bausch & Lomb Incorporation |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
|
US20070218103A1
(en)
|
2006-03-15 |
2007-09-20 |
Bausch & Lomb Incorporated |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
|
US20070231360A1
(en)
|
2006-03-28 |
2007-10-04 |
Minu, L.L.C. |
Neural conduit agent dissemination
|
|
US20080166411A1
(en)
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
|
US20070249536A1
(en)
|
2006-04-25 |
2007-10-25 |
Ma Peter X |
Three-component polyanhydride copolymers and a method of forming the same
|
|
US20100003291A1
(en)
|
2006-05-15 |
2010-01-07 |
Liquidia Technologies, Inc. |
Nano-particles for cosmetic applications
|
|
US7691811B2
(en)
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
|
US20080102128A1
(en)
|
2006-07-28 |
2008-05-01 |
Flamel Technologies, Inc. |
Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
|
|
WO2008015220A1
(en)
|
2006-08-04 |
2008-02-07 |
Ethypharm |
Granule and orally disintegrating tablet comprising oxycodone
|
|
DE602007012559D1
(de)
|
2006-09-08 |
2011-03-31 |
Univ Johns Hopkins |
H die schleimhaut
|
|
US8821943B2
(en)
|
2006-09-12 |
2014-09-02 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
|
US7579021B2
(en)
|
2006-09-27 |
2009-08-25 |
Bausch & Lomb Incorporated |
Drug delivery systems based on degradable cationic siloxanyl macromonomers
|
|
US8394488B2
(en)
|
2006-10-06 |
2013-03-12 |
Cordis Corporation |
Bioabsorbable device having composite structure for accelerating degradation
|
|
US8586556B2
(en)
*
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
CN101553206B
(zh)
|
2006-11-09 |
2012-11-21 |
爱尔康研究有限公司 |
用于药物递送的水不溶性聚合物基质
|
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US7659259B2
(en)
|
2006-12-21 |
2010-02-09 |
Bausch & Lomb Incorporated |
Method of treating inflammation of the eye
|
|
US20090202615A1
(en)
|
2007-02-19 |
2009-08-13 |
Plurogen Therapeutics, Inc. |
Compositions for Treating Biofilms and Methods for Using Same
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
CN101317847B
(zh)
|
2007-06-06 |
2010-10-13 |
深圳市瑞谷医药技术有限公司 |
一种眼用或耳鼻用药物组合物及其用途
|
|
WO2009018092A1
(en)
|
2007-07-27 |
2009-02-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Supramolecular functionalization of graphitic nanoparticles for drug delivery
|
|
CN101129385B
(zh)
|
2007-08-14 |
2010-07-21 |
山东博士伦福瑞达制药有限公司 |
含加替沙星和依碳酸氯替泼诺的眼用组合物及其制备方法
|
|
EA019867B1
(ru)
|
2007-10-08 |
2014-06-30 |
Фовея Фармасьютикалс |
Водные офтальмологические препараты
|
|
JP2011502990A
(ja)
*
|
2007-11-05 |
2011-01-27 |
ボーシュ アンド ローム インコーポレイティド |
薬物送達用ビヒクルとしての水非混和性物質
|
|
US20090203709A1
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
|
|
US20090226531A1
(en)
|
2008-03-07 |
2009-09-10 |
Allergan, Inc. |
Methods and composition for intraocular delivery of therapeutic sirna
|
|
US20100008993A1
(en)
|
2008-07-14 |
2010-01-14 |
Proksch Joel W |
Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs
|
|
TWI580441B
(zh)
|
2008-09-19 |
2017-05-01 |
愛爾康研究有限公司 |
穩定的藥學次微米懸浮液及其形成方法
|
|
EP2355853B1
(en)
|
2008-10-10 |
2016-12-07 |
Polyactiva Pty Ltd |
Biodegradable polymer - bioactive moiety conjugates
|
|
US20120052041A1
(en)
|
2009-02-04 |
2012-03-01 |
The Brigham And Women's Hospital, Inc. |
Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
|
|
JP5583146B2
(ja)
|
2009-03-03 |
2014-09-03 |
アルコン リサーチ， リミテッド |
レセプターチロシンキナーゼ阻害（ＲＴＫｉ）化合物の眼への送達のための薬学的組成物
|
|
EA201171195A8
(ru)
|
2009-03-30 |
2014-08-29 |
Серулин Фарма Инк. |
Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
|
|
US10952965B2
(en)
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
|
EP2335686A1
(en)
|
2009-12-21 |
2011-06-22 |
LEK Pharmaceuticals d.d. |
An aqueous intravenous nanosuspension with reduced adverse effects
|
|
JP5560719B2
(ja)
|
2010-01-08 |
2014-07-30 |
東レ株式会社 |
親水性生理活性物質含有微粒子の製造方法
|
|
AU2011212941B2
(en)
|
2010-02-03 |
2016-03-03 |
Microbion Corporation |
Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
|
|
WO2011106168A1
(en)
|
2010-02-24 |
2011-09-01 |
Dcam Pharma Inc |
Purine compounds for treating autoimmune and demyelinating diseases
|
|
EP2538929A4
(en)
|
2010-02-25 |
2014-07-09 |
Univ Johns Hopkins |
DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
|
|
WO2011109384A2
(en)
|
2010-03-02 |
2011-09-09 |
Allergan, Inc. |
Biodegradable polymers for lowering intraocular pressure
|
|
JP5921535B2
(ja)
|
2010-06-16 |
2016-05-24 |
ディナバックス テクノロジーズ コーポレイション |
Ｔｌｒ７および／またはｔｌｒ９阻害剤を用いる治療の方法
|
|
DE102010023949A1
(de)
|
2010-06-16 |
2011-12-22 |
F. Holzer Gmbh |
In-situ Lecithin-Mikroemulsionsgel-Formulierung
|
|
US20120252756A1
(en)
|
2010-06-25 |
2012-10-04 |
Coffey Martin J |
Pharmaceutical Compositions and Methods for Treating, Controlling, Ameliorating, or Reversing Conditions of the Eye
|
|
EP2598131A1
(fr)
|
2010-07-29 |
2013-06-05 |
Laboratoires Fournier S.A. |
Composes pour le traitement/la prevention des maladies inflammatoires oculaires
|
|
WO2012014114A1
(en)
|
2010-07-30 |
2012-02-02 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
MX2013003360A
(es)
|
2010-09-24 |
2013-06-05 |
Ranbaxy Lab Ltd |
Inhibidores de metaloproteinasa de matriz.
|
|
SG188642A1
(en)
|
2010-09-24 |
2013-05-31 |
Ranbaxy Lab Ltd |
Matrix metalloproteinase inhibitors
|
|
WO2012038944A1
(en)
|
2010-09-24 |
2012-03-29 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
EP2629760A4
(en)
|
2010-10-22 |
2014-04-02 |
Bind Therapeutics Inc |
THERAPEUTIC NANOPARTICLES CONTAINING COPOLYMERS OF HIGH MOLECULAR WEIGHT
|
|
WO2012061703A1
(en)
|
2010-11-05 |
2012-05-10 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
DE102010050570A1
(de)
|
2010-11-05 |
2012-05-10 |
F. Holzer Gmbh |
Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors
|
|
US9657292B2
(en)
|
2010-11-24 |
2017-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Compositions and methods for treating or preventing lupus
|
|
WO2012074980A2
(en)
|
2010-12-01 |
2012-06-07 |
Dara Biosciences, Inc. |
Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives
|
|
AR084433A1
(es)
|
2010-12-22 |
2013-05-15 |
Ironwood Pharmaceuticals Inc |
Inhibidores de la faah y composiciones farmaceuticas que los contienen
|
|
WO2012088431A1
(en)
|
2010-12-23 |
2012-06-28 |
Ironwood Pharmaceuticals, Inc. |
Faah inhibitors
|
|
WO2012093117A1
(en)
|
2011-01-03 |
2012-07-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
EP2688890B1
(en)
|
2011-03-22 |
2017-08-30 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
|
EP2701742A4
(en)
|
2011-04-26 |
2015-03-18 |
Genentech Inc |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES
|
|
US8835410B2
(en)
|
2011-05-10 |
2014-09-16 |
Bodor Laboratories, Inc. |
Treatment of eyelid dermatitis
|
|
CA2835343A1
(en)
|
2011-05-12 |
2012-11-15 |
Foresight Biotherapeutics, Inc. |
Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories
|
|
WO2012162698A1
(en)
|
2011-05-26 |
2012-11-29 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the treatment of immune disorders
|
|
CN102311395B
(zh)
|
2011-07-05 |
2014-04-16 |
张爱华 |
喹唑啉环取代的二苯脲类衍生物及其用途
|
|
US8859525B2
(en)
|
2011-07-19 |
2014-10-14 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
|
|
TW202023575A
(zh)
|
2011-09-16 |
2020-07-01 |
美商遠景生物製藥股份有限公司 |
安定之普維酮—碘組成物
|
|
WO2013061269A1
(en)
|
2011-10-26 |
2013-05-02 |
Micro Labs Limited |
Combinations of loteprednol and olopatadine for the treatment of ocular allergies
|
|
WO2013065028A1
(en)
|
2011-11-04 |
2013-05-10 |
Micro Labs Limited |
Fixed dose combination containing azithromycin and loteprednol for treatment of ocular infections
|
|
CN104105507B
(zh)
|
2011-12-14 |
2020-03-24 |
约翰霍普金斯大学 |
增强粘膜渗透或减少炎症的纳米粒子
|
|
US20130217657A1
(en)
|
2011-12-21 |
2013-08-22 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
|
US9437409B2
(en)
|
2011-12-27 |
2016-09-06 |
Dh Technologies Development Pte. Ltd. |
High voltage power supply filter for a mass spectrometer
|
|
RU2598627C2
(ru)
|
2012-01-19 |
2016-09-27 |
Дзе Джонс Хопкинс Юниверсити |
Композиции на основе наночастиц с улучшенным проникновением через слизистые оболочки
|
|
US9278132B2
(en)
|
2012-02-13 |
2016-03-08 |
Bausch & Lomb Incorporated |
Ophthalmic pharmaceutical compositions and methods of making and using same
|
|
CN104363924B
(zh)
|
2012-03-16 |
2018-04-17 |
约翰霍普金斯大学 |
用于递送hif‑1抑制剂的控制释放调配物
|
|
JP6138904B2
(ja)
|
2012-03-16 |
2017-05-31 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
|
|
US20140107025A1
(en)
|
2012-04-16 |
2014-04-17 |
Jade Therapeutics, Llc |
Ocular drug delivery system
|
|
ES3055223T3
(en)
|
2012-05-03 |
2026-02-10 |
Alcon Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
KR102140989B1
(ko)
|
2012-05-03 |
2020-08-04 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
US10864219B2
(en)
*
|
2012-05-03 |
2020-12-15 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
KR20150006869A
(ko)
*
|
2012-05-03 |
2015-01-19 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
AU2013256008B2
(en)
|
2012-05-04 |
2016-02-25 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
KR20150056619A
(ko)
|
2012-09-17 |
2015-05-26 |
바인드 쎄라퓨틱스, 인크. |
치료제를 포함하는 치료 나노입자 및 그의 제조 및 사용 방법
|
|
KR20150090038A
(ko)
|
2012-09-20 |
2015-08-05 |
아키나, 인크. |
충전재를 함유한 생분해성 미세캡슐
|
|
EP2968113B8
(en)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
RU2015146211A
(ru)
|
2013-04-01 |
2017-05-19 |
Аллерган, Инк. |
Микросферная система доставки лекарственного средства для замедленного внутриглазного высвобождения
|
|
UA119324C2
(uk)
|
2013-04-02 |
2019-06-10 |
Теміс Медікер Лімітед |
Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
|
|
US20140378401A1
(en)
|
2013-06-21 |
2014-12-25 |
Gnt, Llc |
Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
|
|
KR20160099084A
(ko)
*
|
2013-11-01 |
2016-08-19 |
칼라 파마슈티컬스, 인크. |
치료 화합물의 결정질 형태 및 그의 용도
|